G01N 33/577
Involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal
Official title: involving monoclonal antibodies {binding reaction mechanisms characterised by the use of monoclonal antibodies (G01N33/5302 - G01N33/576 take precedence)}
G01N33/577 (Involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal) appears on 510 US grants and 784 published applications in this corpus.
Search patents in G01N- Granted patents
- 510
- Published applications
- 784
- Assignees
- 515
- Inventors
- 1,847
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 2 | 0 |
| 1984 | 9 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 10 | 0 |
| 1988 | 9 | 0 |
| 1989 | 5 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 5 |
| 2003 | 2 | 8 |
| 2004 | 4 | 5 |
| 2005 | 3 | 11 |
| 2006 | 1 | 4 |
| 2007 | 2 | 7 |
| 2008 | 5 | 4 |
| 2009 | 3 | 14 |
| 2010 | 6 | 12 |
| 2011 | 6 | 28 |
| 2012 | 5 | 23 |
| 2013 | 13 | 26 |
| 2014 | 22 | 33 |
| 2015 | 15 | 32 |
| 2016 | 31 | 62 |
| 2017 | 25 | 49 |
| 2018 | 29 | 56 |
| 2019 | 37 | 58 |
| 2020 | 48 | 73 |
| 2021 | 36 | 61 |
| 2022 | 42 | 53 |
| 2023 | 25 | 40 |
| 2024 | 30 | 53 |
| 2025 | 29 | 43 |
| 2026 | 21 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Luciferase linked immunosorbent assay6 Oct 2026US 12,753,245 B2Institut Pasteur
- Galectin-3 immunoassay22 Sep 2026US 12,742,787 B2BG Medicine, Inc.
- Anti-idiotype antibody molecules and uses thereof25 Aug 2026US 12,715,934 B2Otsuka Pharmaceutical Co., Ltd.
- Method for capturing and identifying cellular agglutinates for detecting multiplex anti-erythrocyte antibodies21 Jul 2026US 12,687,553 B2Innobiochips
- Anti-interleukin-17A antibody, pharmaceutical composition thereof and use thereof14 Jul 2026US 12,679,887 B2Akeso Biopharma, Inc.
- Anti-interleukin-17a antibody, pharmaceutical composition thereof and use thereof24 Sep 2026US 2026/0285969 A1Akeso Biopharma, Inc.
- Anti-ctla4 and anti-pd-1 bifunctional antibody, pharmaceutical composition thereof and use thereof17 Sep 2026US 2026/0274952 A1Akeso Pharmaceuticals, Inc.
- C3F Assay10 Sep 2026US 2026/0266829 A1Nordic Bioscience A/S
- Method for obtaining information on renal amyloidosis, method for assisting diagnosis of renal amyloidosis, and reagent kit10 Sep 2026US 2026/0266846 A1National University Corporation Kumamoto University
- Anti-mesothelin antibodies and uses thereof3 Sep 2026US 2026/0258148 A1Phanes Therapeutics, Inc.
Most cited
By later US patents
- Immunometric assays using monoclonal antibodies1,218US 4,376,110 AHybritech Incorporated · 1983
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988
- Multiepitopic immunometric assay310US 5,011,771 AThe General Hospital Corporation · 1991
- Immunometric assays using monoclonal antibodies291US 4,486,530 AHybritech Incorporated · 1984
- Immunoassay of antigens199US 4,659,678 ASerono Diagnostics Ltd. · 1987